Written by Private MD Labs Medical Writing Team • Last Updated: September 8, 2025
Rheumatoid arthritis (RA) is a chronic autoimmune disorder that primarily affects the joints, causing inflammation, pain, and potential joint damage. While diagnosis involves clinical evaluation and imaging, blood tests play a crucial role in confirming the diagnosis, assessing disease activity, and monitoring treatment response.
This comprehensive panel includes both CCP antibodies and Rheumatoid Factor. CCP antibodies are highly specific for RA and can be found in 60-80% of patients, sometimes appearing years before symptoms develop. Rheumatoid Factor is found in approximately 80% of those with RA and helps indicate the presence and severity of the disease.
Blood tests are fundamental for diagnosing rheumatoid arthritis because they can detect specific antibodies and inflammatory markers that are characteristic of the disease. These tests help distinguish RA from other types of arthritis and provide valuable information about disease severity and progression.
The presence of CCP antibodies is strongly associated with rheumatoid arthritis, found in about 60% to 80% of patients with this condition. These antibodies are highly specific for RA and can appear years before any symptoms develop, making this test valuable for early diagnosis.
High levels of Rheumatoid Factor in the blood are a common indicator of rheumatoid arthritis. This antibody is found in the majority of RA patients and helps confirm the diagnosis, although it can also be present in other conditions.
High levels of CRP are commonly seen in people with rheumatoid arthritis due to the inflammation caused by the disease. This test helps monitor disease activity and response to treatment.
Elevated levels of high-sensitivity CRP are seen in inflammatory conditions like rheumatoid arthritis. As the immune system attacks the joints, inflammation occurs and CRP levels increase, making this a sensitive marker for disease monitoring.
An elevated sedimentation rate is often found in patients with rheumatoid arthritis. It indicates inflammation and active disease, making it useful for monitoring disease progression and treatment effectiveness.
IL-6 is an inflammatory cytokine that plays a crucial role in the pathogenesis of rheumatoid arthritis. High levels of serum IL-6 are often found in patients with active rheumatoid arthritis and can help assess disease activity.
High levels of Interleukin-1 Beta are typically found in individuals with rheumatoid arthritis, as this cytokine plays a key role in inflammatory and immunological responses characteristic of the disease.
Interleukin 17 plays a significant role in the inflammation and joint destruction associated with rheumatoid arthritis. Elevated levels can indicate disease activity and help monitor treatment response.
A positive ANA Screen can be seen in rheumatoid arthritis patients, although it is not specific to RA. This test helps identify autoimmune activity and can be useful as part of a comprehensive autoimmune evaluation.
Certain HLA DRB1 alleles are associated with an increased risk of rheumatoid arthritis. The presence of these alleles can trigger an immune response leading to inflammation and joint damage, making this test valuable for assessing genetic predisposition.
Certain alleles of the HLA-DRB1 gene, such as DRB1*04 and DRB1*01, are associated with an increased risk of developing rheumatoid arthritis. This comprehensive high-resolution test provides detailed genetic information about RA susceptibility.
The information provided here is for educational purposes only and is not a substitute for professional medical advice. Rheumatoid arthritis diagnosis requires comprehensive evaluation by a healthcare provider, combining clinical symptoms, physical examination, imaging studies, and laboratory tests. Always consult with a rheumatologist or healthcare provider for proper diagnosis and treatment of rheumatoid arthritis.